C92.1 - Chronic myeloid leukemia, BCR/ABL-positive
- Applicable to Chronic myeloid leukemia, BCR/ABL-positive
- The 2025 edition of ICD10-CM C92.1 became effective on October 1, 2024.
- This is the American ICD10-CM version of C92.1 - other international versions of ICD10 C92.1 may differ.
- C92.1 is a Non-Billable / Non-Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- C92.1 Code should not be used for billing or reimbursement purposes as there are multiple ICD-10 CM codes below it that contain a greater level of detail.
- C92.1 - Chronic myeloid leukemia, BCR/ABL-positive
- C92.1 - Chronic myeloid leukemia, BCR/ABL-positive
- C92.10 - Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission
- C92.11 - Chronic myeloid leukemia, BCR/ABL-positive, in remission
- C92.12 - Chronic myeloid leukemia, BCR/ABL-positive, in relapse
Inclusion terms help to clarify and specify the conditions or diseases covered by a particular ICD-10-CM code.
Inclusion Term:
- Chronic myelogenous leukemia, Philadelphia chromosome (Ph1) positive
- Chronic myelogenous leukemia, t(9;22) (q34;q11)
- Chronic myelogenous leukemia with crisis of blast cells
Type 1 Excludes
- atypical chronic myeloid leukemia BCR/ABL-negative (C92.2-)
- chronic myelomonocytic leukemia (C93.1-)
- chronic myeloproliferative disease (D47.1)
Non-Billable/Non-Specific Code
The following codes above C92.1 contain annotation back-references that may be applicable to C92.1:
- Chapter: C00-D49 - Neoplasms
- Section: C81-C96 - Malignant neoplasms of lymphoid, hematopoietic and related tissue
- Category: C92 - Myeloid leukemia
Browse other similar CM codes:
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd10all.com